8279 logo

Syngen Biotech Co.,Ltd. Stock Price

TPEX:8279 Community·NT$3.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

8279 Share Price Performance

NT$129.00
-1.00 (-0.77%)
NT$129.00
-1.00 (-0.77%)
Price NT$129.00

8279 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

0 Risks
3 Rewards

Syngen Biotech Co.,Ltd. Key Details

NT$2.1b

Revenue

NT$1.4b

Cost of Revenue

NT$759.9m

Gross Profit

NT$467.7m

Other Expenses

NT$292.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
10.78
35.65%
13.71%
5.1%
View Full Analysis

About 8279

Founded
1988
Employees
n/a
CEO
Wei Chen
WebsiteView website
www.syngen.com.tw

Syngen Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally. The company offers dietary supplements; supplement contract manufacturing services in the form of sachets, liquids, tablets, cup package capsules, jellies, aluminum and glass bottles, and gummies; science-based and bio active pharmaceutical ingredients under the Oraltics, IMMUPHYLA, V3, ST4SanTex, GUARDSPO, benefiGANO, EXPUNERGY, and BIOJOVIAL brands; and private labelling services. It also provides organic food OEM/ODM, explosion proof extraction, brand agency, and wholesale distribution services. The company serves the sport nutrition, beauty enhancement, baby and mother care, weight management, and digestion and detox industries. It exports to approximately 20 countries. Syngen Biotech Co.,Ltd. was founded in 1988 and is based in Tainan City, Taiwan.

Recent 8279 News & Updates

Recent updates

No updates